Please wait a minute...
90Life Research  2019, Vol. 2 Issue (3): 93-98    DOI: 10.12032/life2019-0725-301
Review     
A summary of the pharmacologically tested aphrodisiac plants for sexual dysfunction
Marko Mornar Jelavic1,2,4,*(), Hrvoje Pintaric2,3,4
1Institute for Cardiovascular Prevention and Rehabilitation, Zagreb, Croatia.
2School of Dental Medicine, University of Zagreb, Zagreb, Croatia.
3University Hospital Center "Sestre milosrdnice", Clinic for Internal Medicine, Department of Emergency Medicine, Zagreb, Croatia.
4These authors contributed equaly to this work.
Download: HTML     PDF(1003KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Sexual dysfunction is a disruption of normal sexual intercourse and may be a consequence of various organic and psychological disorders. It is the most frequent at patients with cardiovascular and neurological diseases sedentary lifestyle arterial hypertension diabetes obesity and metabolic syndrome and may disrupt their emotional life. But sexual dysfunction may occur simply because of the physical aging of the body. Physiologic changes that occur with aging will affect sexual function and could be exacerbated by the above-mentioned diseases. Except for the sexual counseling and standard medications (phosphodiesterase type 5 (PDE5) - inhibitors local estrogen therapy) some of the herbal medicines (aphrodisiacs) may be helpful in the treatment of these patients making them emotionally younger and happier. In this review we bring a list of the pharmacologically tested aphrodisiac plants. But we have a lack of information about their mechanisms of action drug interaction and safety profile. Until the relevant information is collected uses of these products may be risky to the human being and should be prescribed only in consultation with a specialist. Sexual dysfunction is a disruption of normal sexual intercourse and may be a consequence of various organic and psychological disorders. It is the most frequent at patients with cardiovascular and neurological diseases sedentary lifestyle arterial hypertension diabetes obesity and metabolic syndrome and may disrupt their emotional life. But sexual dysfunction may occur simply because of the physical aging of the body. Physiologic changes that occur with aging will affect sexual function and could be exacerbated by the above-mentioned diseases. Except for the sexual counseling and standard medications (phosphodiesterase type 5 (PDE5) - inhibitors local estrogen therapy) some of the herbal medicines (aphrodisiacs) may be helpful in the treatment of these patients making them emotionally younger and happier. In this review we bring a list of the pharmacologically tested aphrodisiac plants. But we have a lack of information about their mechanisms of action drug interaction and safety profile. Until the relevant information is collected uses of these products may be risky to the human being and should be prescribed only in consultation with a specialist.



Key wordsSexual dysfunction      Erectile dysfunction      Herbal medicines      Aphrodisiacs     
Published: 25 July 2019
Corresponding Authors: Mornar Jelavic Marko   
E-mail: mjelavic@yahoo.com
Cite this article:

Marko Mornar Jelavic, Hrvoje Pintaric. A summary of the pharmacologically tested aphrodisiac plants for sexual dysfunction. 90Life Research, 2019, 2(3): 93-98.

Trendmd:

URL:

https://www.tmrjournals.com/lr/EN/10.12032/life2019-0725-301     OR     https://www.tmrjournals.com/lr/EN/Y2019/V2/I3/93

[1]   Nehra A.Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.Mayo Clin Proc. 2009; 84:139-148.
[2]   Bailey LA, Hoffman D.Female sexual dysfunction: a nontraditional risk factor for cardiovascular disease.Curr Sex Health Rep .2008; 5:208-212.
doi: 10.1007/s11930-008-0036-3
[3]   Kotta S, Ansari SH, Ali J.Exploring scientifically proven herbal aphrodisiacs. Pharmacogn Rev.2013; 7:1-10.
[4]   Pallavi KJ, Ramandeep S, Sarabjeet S, et al.Aphrodisiac agents from medicinal plants: A review.J Chem Pharm Res.2011; 3:911-921.
[5]   Guay AT, Spark RF, Bansal S, et al.American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: A couple’s problem - 2003 update.Endocr Pract. 2003; 9:77-95.
doi: 10.4158/EP.9.1.77
[6]   Martey ON, He X.Possible mode of action of Mondia whitei: An aphrodisiac used in the management of erectile dysfunction.J Pharmacol Toxicol. 2010; 5:460-468.
doi: 10.3923/jpt.2010.460.468
[7]   Davis MW.Consumer’s Guide to Dietary Supplements and Alternativne Medicines: Servings of Hope. 1st ed. Pharmaceutical Products Press. New York (USA). 2006. Chapter 16, Supplements and Superior Sex; p.203-221.
[8]   Basson R.Women’s sexual function and dysfunction: current uncertainties, future directions. Int J Impot Res.2008; 20:466.
[9]   Allahdadi KJ, Tostes RC, Webb RC.Female sexual dysfunction: therapeutic options and experimental challenges.Cardiovasc Hematol Agents Med Chem. 2009; 7:260-269.
doi: 10.2174/187152509789541882
[10]   Levine GN, Steinke EE, Bakaeen FG, et al.Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation .2012; 125:1058-72.
doi: 10.1161/CIR.0b013e3182447787
[11]   Olsson AM, Persson CA, Swedish Sildenafil Investigators Group. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease.Int J Clin Pract .2001; 55:171-176.
[12]   Kloner RA.Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.Circulation. 2004; 110:3149-3155.
[13]   Morales AM, Mirone V, Dean J, et al.Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.Clin Interv Aging .2009; 4:463-472.
[14]   Simon JA, Kingsberg SA, Shumel B, et al.Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the Snowdrop trial.Menopause.2014; 21:633-640.
[15]   DeRogatis LR, Komer L, Katz M, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the Violet study.J Sex Med.2012; 9:1074-1085.
doi: 10.1111/j.1743-6109.2011.02626.x
[16]   Jayne C, Simon JA, Taylor LV, et al.Sunflower study investigators. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.J Sex Med .2012; 9:3180-3188.
[17]   Thorp J, Simon J, Dattani D, et al.DAISY trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.J Sex Med .2012; 9:793-804.
[18]   Katz M, DeRogatis LR, Ackerman R, et al. Begonia trial investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the Begonia trial.J Sex Med. 2013; 10:1807-1815.
doi: 10.1111/jsm.12189
[19]   Lindau ST, Schumm LP, Laumann EO, et al.A study of sexuality and health among older adults in the United States.N Engl J Med .2007; 357:762-774.
doi: 10.1056/NEJMoa067423
[20]   Hulley S, Grady D, Bush T, et al.Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.JAMA .1998; 280:605-613.
doi: 10.1001/jama.280.7.605
[21]   Rossouw JE, Anderson GL, Prentice RL, et al.Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.JAMA .2002; 288:321-333.
doi: 10.1001/jama.288.3.321
[22]   Ponzone R, Biglia N, Jacomuzzi ME, et al.Vaginal oestrogen therapy after breast cancer: is it safe?Eur J Cancer. 2005; 41:2673-2681.
doi: 10.1016/j.ejca.2005.07.015
[23]   Ali ST, Rakkah NI.Probable neuro sexual mode of action of Casimiroa edulis seed extract versus correction of verses sildenafil citrate (Viagra (tm)) on mating behavior in normal male rats. Pak J Pharm Sci.2008; 21:1-6.
[24]   Thakur M, Chauhan NS, Bhargava S, et al.A comparative study on aphrodisiac activity of some ayurvedic herbs in male albino rats.Arch Sex Behav. 2009; 38:1009-1015.
doi: 10.1007/s10508-008-9444-8
[25]   Kenjale R, Shah R, Sathaye S.Effects of Chlorophytum borivilianum on sexual behaviour and sperm count in male rats.Phytother Res. 2008; 22:796-801.
doi: 10.1002/(ISSN)1099-1573
[26]   Hosseinzadeh H, Ziaee T, Sadeghi A.The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats.Phytomedicine .2008; 15:491-495.
doi: 10.1016/j.phymed.2007.09.020
[27]   Ang HH, Ikeda S, Gan EK.Evaluation of the potency activity of aphrodisiac in Eurycoma longifolia Jack. Phytother Res.2001; 15:435-436.
[28]   Yakubu MT, Akanji MA, Oladiji AT.Effects of oral administration of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem on some testicular function indices of male rats.J Ethnopharmacol.2008; 115:288-292.
[29]   Zheng BL, He K, Kim CH, et al.Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats.Urology. 2000; 55:598-602.
doi: 10.1016/S0090-4295(99)00549-X
[30]   Gonzales GF, Córdova A, Vega K, et al.Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia.2002; 34:367-372.
[31]   Gonzales GF, Cordova A, Vega K, et al.Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men.J Endocrinol. 2003; 176:163-168.
doi: 10.1677/joe.0.1760163
[32]   Lampiao F, Krom D, du Plessis SS. The in vitro effects of Mondia whitei on human sperm motility parameters.Phytother Res. 2008; 22:1272-1273.
doi: 10.1002/ptr.2469
[33]   Carro-Juarez M, Cervantes E, Cervantes-Méndez M, et al.Aphrodisiac properties of Montanoa tomentosa aqueous crude extract in male rats.Pharmacol Biochem Behav. 2004; 78:129-134.
doi: 10.1016/j.pbb.2004.03.001
[34]   Carro-Juarez M, Lobaton I, Benítez O, et al.Pro-ejaculatory effect of the aqueous crude extract of cihuapatli (Montanoa tomentosa) in spinal male rats. J Ethnopharmacol.2006; 106:111-116.
[35]   Chen X.Cardiovascular protection by ginsenosides and their nitric oxide releasing action.Clin Exp Pharmacol Physiol. 1996; 23:728-732.
doi: 10.1111/cep.1996.23.issue-8
[36]   Adeniyi AA, Brindley GS, Pryor JP, et al.Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl.2007; 9:403-407.
[37]   Bahmanpour S, Talaei T, Vojdani Z, et al.Effect of Phoenix dactylifera pollen on sperm parameters and reproductive system of adult male rats. Iran J Med Sci. 2006; 31:208-212.
[38]   Rezvanfar M, Sadrkhanlou R, Ahmadi A, et al.Protection of cyclophosphamide-induced toxicity in reproductive tract histology, sperm characteristics, and DNA damage by an herbal source; evidence for role of free-radical toxic stress. Hum Exp Toxicol.2008; 27:901-910.
[39]   Ratnasooriya WD, Dharmasiri MG.Effects of Terminalia catappa seeds on sexual behaviour and fertility of male rats. Asian J Androl.2000; 2:213-219.
[40]   Patel DK, Kumar R, Prasad SK, et al.Pharmacologically screened aphrodisiac plant: A review of current scientific literature. Asian Pac J Trop Biomed .2011; 1:131-138.
[41]   Neychev VK, Mitev VI.The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men. J Ethnopharmacol.2005; 101:319-323.
[42]   Tomova M, Gjulemetova R, Zarkova S, et al.Steroidal saponins from Tribulus terrestris L. with a stimulating action on the sexual functions.Int Conf Chem Biotechnol .1981;3:298-302.
[43]   Adimoelja A, Adaikan PG.Protodioscin from herbal plant Tribulus terrestris L. improves male sexual functions possibly via DHEA.Int J Impot Res .1997; 9:64-74.
[44]   Gauthaman K, Adaikan PG, Prasad RN, et al.Changes in hormonal parameters secondary to intravenous administration of Tribulus terrestris extract in primates.Int J Impot Res .2000; 2:6.
[45]   Estrada-Reyes R, Ortiz-Lopez P, Gutierrez-Ortiz J, et al.Turnera diffusa Wild (Turneraceae) recovers sexual behavior in sexually exhausted males. J Ethnopharmacol.2009; 123:423-429.
[46]   Kearney T, Tu N, Haller C.Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother.2010; 44:1022-1029.
[47]   Aoki H, Nagao J, Ueda T, et al.Clinical assessment of a supplement of Pycnogenol and L-arginine in Japanese patients with mild to moderate erectile dysfunction. Phytother Res.2012; 26:204-207.
[48]   Musso NR, Vergassola C, Pende A, et al.Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens.1995; 8:565-571.
[49]   Schulman SP, Becker LC, Kass DA, et al.L-arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA.2006; 295:58-64.
No related articles found!